MAP2K7 and COVID-19: In order to discuss this, it is worth emphasizing that the previous studies on RAF/MEK/ERK were restricted to patients with moderate-to-severe COVID-19, i.e., without viral sepsis, and those receiving intensive care treatment or needing ventilator support were excluded.